Follow
Hiroyoshi Y. Tanaka
Hiroyoshi Y. Tanaka
Asst Prof, Department of Pharmaceutical Biomedicine, Okayama University
Verified email at okayama-u.ac.jp
Title
Cited by
Cited by
Year
Stromal Barriers to Nanomedicine Penetration in the Pancreatic Tumor Microenvironment
HY Tanaka, MR Kano
Cancer Science 109 (7), 2085-2092, 2018
792018
In vivo rendezvous of small nucleic acid drugs with charge-matched block catiomers to target cancers
S Watanabe, K Hayashi, K Toh, HJ Kim, X Liu, H Chaya, S Fukushima, ...
Nature Communications 10 (1), 1894, 2019
622019
Secretions from placenta, after hypoxia/reoxygenation, can damage developing neurones of brain under experimental conditions
DJ Curtis, A Sood, TJ Phillips, VHL Leinster, A Nishiguchi, C Coyle, ...
Experimental Neurology 261, 386-395, 2014
482014
Pancreatic stellate cells derived from human pancreatic cancer demonstrate aberrant SPARC-dependent ECM remodeling in 3D engineered fibrotic tissue of clinically relevant thickness
HY Tanaka, K Kitahara, N Sasaki, N Nakao, K Sato, H Narita, H Shimoda, ...
Biomaterials 192, 355-367, 2019
352019
Heterotypic 3D pancreatic cancer model with tunable proportion of fibrotic elements
HY Tanaka, T Kurihara, T Nakazawa, M Matsusaki, A Masamune, ...
Biomaterials 251, 120077, 2020
282020
Increased fibrosis and impaired intratumoral accumulation of macromolecules in a murine model of pancreatic cancer co-administered with FGF-2
S Sakai, C Iwata, HY Tanaka, H Cabral, Y Morishita, K Miyazono, ...
Journal of Controlled Release 230, 109-115, 2016
272016
Desmoplastic Reaction in 3D‐Pancreatic Cancer Tissues Suppresses Molecular Permeability
M Matsusaki, M Komeda, S Mura, HY Tanaka, MR Kano, P Couvreur, ...
Advanced Healthcare Materials 6 (15), 1700057, 2017
222017
Pattern of antibiotic prescriptions for outpatients with acute respiratory tract infections in Japan, 2013–15: a retrospective observational study
Y Teratani, H Hagiya, T Koyama, M Adachi, A Ohshima, Y Zamami, ...
Family Practice 36 (4), 402-409, 2019
182019
3D in vitro model of vascular medial thickening in pulmonary arterial hypertension
C Morii, HY Tanaka, Y Izushi, N Nakao, M Yamamoto, H Matsubara, ...
Frontiers in Bioengineering and Biotechnology 8, 482, 2020
162020
Antibiotic prescriptions for Japanese outpatients with acute respiratory tract infections (2013–2015): A retrospective observational study
T Koyama, H Hagiya, Y Teratani, Y Tatebe, A Ohshima, M Adachi, ...
Journal of Infection and Chemotherapy 26 (7), 660-666, 2020
122020
Oral anticoagulants usage in Japanese patients aged 18–74 years with non-valvular atrial fibrillation: a retrospective analysis based on insurance claims data
A Ohshima, T Koyama, A Ogawa, Y Zamami, HY Tanaka, Y Kitamura, ...
Family Practice 36 (6), 685-692, 2019
82019
Regulation of endothelial Fas expression as a mechanism of promotion of vascular integrity by mural cells in tumors
R Kamei, HY Tanaka, T Kawano, C Morii, S Tanaka, H Nishihara, C Iwata, ...
Cancer Science 108 (5), 1080-1088, 2017
82017
Therapeutic strategies to overcome fibrotic barriers to nanomedicine in the pancreatic tumor microenvironment
HY Tanaka, T Nakazawa, A Enomoto, A Masamune, MR Kano
Cancers 15 (3), 724, 2023
52023
Modeling and Analysis of Disease Microenvironments with 3D Cell Culture Technology
HY Tanaka
Yakugaku Zasshi 141 (5), 647-653, 2021
32021
Stromal barriers within the tumor microenvironment and obstacles to nanomedicine
HY Tanaka, MR Kano
Cancer Drug Delivery Systems Based on the Tumor Microenvironment, 57-89, 2019
22019
Targeting ROCK2 improves macromolecular permeability in a 3D fibrotic pancreatic cancer microenvironment model
HY Tanaka, T Nakazawa, T Miyazaki, H Cabral, A Masamune, MR Kano
Journal of Controlled Release 369, 283-295, 2024
2024
がん微小環境における線維化とナノ DDS(特集 がん微小環境の理解に基づくナノ DDS の展開)
田中啓祥, 狩野光伸
Drug Delivery System 36 (4), 232-240, 2021
2021
三次元培養技術によるがん微小環境の in vitro での再現と DDS 研究への応用(DDS の 「ちょっとした」 技術・知識 (第 8 回)がんモデルの選定)
田中啓祥, 栗原毅, 狩野光伸
Drug Delivery System 35 (5), 445-447, 2020
2020
The system can't perform the operation now. Try again later.
Articles 1–18